Zhihou Liang

2.9k total citations
48 papers, 2.4k citations indexed

About

Zhihou Liang is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Zhihou Liang has authored 48 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 19 papers in Cellular and Molecular Neuroscience and 16 papers in Molecular Biology. Recurrent topics in Zhihou Liang's work include Alzheimer's disease research and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neuroscience and Neuropharmacology Research (8 papers). Zhihou Liang is often cited by papers focused on Alzheimer's disease research and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neuroscience and Neuropharmacology Research (8 papers). Zhihou Liang collaborates with scholars based in China, United States and France. Zhihou Liang's co-authors include Cheng‐Xin Gong, Khalid Iqbal, Inge Grundke‐Iqbal, Fei Liu, Xiaoqin Run, Shenggang Sun, Chun‐Ling Dai, Yanxing Chen, Nian Xiong and Moon H. Lee and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and Brain Research.

In The Last Decade

Zhihou Liang

48 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihou Liang China 25 1.0k 912 599 417 327 48 2.4k
Keun‐A Chang South Korea 27 1.0k 1.0× 957 1.0× 463 0.8× 469 1.1× 197 0.6× 74 2.4k
Othman Ghribi United States 34 916 0.9× 942 1.0× 473 0.8× 306 0.7× 234 0.7× 70 2.9k
Ester Verdaguer Spain 33 865 0.9× 1.4k 1.5× 871 1.5× 417 1.0× 230 0.7× 106 3.2k
Anna M. Canudas Spain 31 756 0.8× 1.0k 1.1× 1.0k 1.7× 386 0.9× 226 0.7× 52 2.5k
Virve Cavallucci Italy 22 720 0.7× 895 1.0× 668 1.1× 483 1.2× 163 0.5× 28 2.2k
Waldo Cerpa Chile 31 908 0.9× 1.2k 1.3× 749 1.3× 329 0.8× 220 0.7× 57 2.5k
Guylène Page France 30 891 0.9× 1.1k 1.3× 555 0.9× 465 1.1× 236 0.7× 75 2.4k
Sandra Moreno Italy 35 1.0k 1.0× 1.9k 2.1× 845 1.4× 436 1.0× 398 1.2× 80 3.6k
Panchanan Maiti United States 27 767 0.8× 1.0k 1.1× 508 0.8× 264 0.6× 380 1.2× 44 2.5k
Giuseppina Amadoro Italy 30 1.4k 1.4× 1.1k 1.2× 822 1.4× 375 0.9× 234 0.7× 65 2.5k

Countries citing papers authored by Zhihou Liang

Since Specialization
Citations

This map shows the geographic impact of Zhihou Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihou Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihou Liang more than expected).

Fields of papers citing papers by Zhihou Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihou Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihou Liang. The network helps show where Zhihou Liang may publish in the future.

Co-authorship network of co-authors of Zhihou Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihou Liang. A scholar is included among the top collaborators of Zhihou Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihou Liang. Zhihou Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Zhihou, Hui Xie, & Dongze Wu. (2025). Immune mediated inflammatory diseases: moving from targeted biologic therapy, stem cell therapy to targeted cell therapy. Frontiers in Immunology. 16. 1520063–1520063. 2 indexed citations
2.
Liang, Zhihou, et al.. (2023). Clinical and genetic characteristics in a central-southern Chinese cohort of early-onset Alzheimer's disease. Frontiers in Neurology. 14. 1119326–1119326. 3 indexed citations
3.
Xu, Xiaojun, Weiwei Ruan, Fang Liu, et al.. (2022). 18F-APN-1607 Tau Positron Emission Tomography Imaging for Evaluating Disease Progression in Alzheimer’s Disease. Frontiers in Aging Neuroscience. 13. 789054–789054. 14 indexed citations
4.
Su, Ying, Man‐Fei Deng, Wan Xiong, et al.. (2018). MicroRNA-26a/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson’s Disease. Biological Psychiatry. 85(9). 769–781. 100 indexed citations
5.
Li, Xing, Xiaoqin Run, Zhen Wei, et al.. (2018). Intranasal Insulin Prevents Anesthesia-induced Cognitive Impairments in Aged Mice. Current Alzheimer Research. 16(1). 8–18. 25 indexed citations
6.
Chen, Yanxing, Xiaoqin Run, Zhihou Liang, et al.. (2014). Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice. Frontiers in Aging Neuroscience. 6. 100–100. 43 indexed citations
7.
Liu, Yudong, Ying Su, Jiajia Wang, et al.. (2013). Rapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinase. Neurochemistry International. 62(4). 458–467. 56 indexed citations
8.
Chen, Yanxing, Zhihou Liang, Julie Blanchard, et al.. (2013). Intracerebroventricular Streptozotocin Exacerbates Alzheimer-Like Changes of 3xTg-AD Mice. Molecular Neurobiology. 49(1). 547–562. 87 indexed citations
9.
Jiang, Shuai, et al.. (2012). Wnt/β-catenin pathway regulating glucocorticoids-mediated Alzheimer’s disease-like pathological changes. Chin J Neurol. 45(7). 500–504. 1 indexed citations
10.
Liu, Yudong, Ying Su, Shenggang Sun, et al.. (2012). Tau Phosphorylation and μ-Calpain Activation Mediate the Dexamethasone-Induced Inhibition on the Insulin-Stimulated Akt Phosphorylation. PLoS ONE. 7(4). e35783–e35783. 6 indexed citations
11.
Chen, Yanxing, Zhihou Liang, Julie Blanchard, et al.. (2012). A Non-transgenic Mouse Model (icv-STZ Mouse) of Alzheimer’s Disease: Similarities to and Differences from the Transgenic Model (3xTg-AD Mouse). Molecular Neurobiology. 47(2). 711–725. 226 indexed citations
12.
Xiong, Nian, Min Jia, C. Chen, et al.. (2011). Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y. Neuroscience. 199. 292–302. 88 indexed citations
13.
Xiong, Nian, Jinsha Huang, Chunnuan Chen, et al.. (2011). Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease. Neurobiology of Aging. 33(8). 1777–1791. 85 indexed citations
14.
Run, Xiaoqin, Zhihou Liang, & Cheng‐Xin Gong. (2010). Anesthetics and Tau Protein: Animal Model Studies. Journal of Alzheimer s Disease. 22(s3). S49–S55. 18 indexed citations
15.
Xiong, Nian, Jinsha Huang, Chunying Chen, et al.. (2010). VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson’s disease. Gene Therapy. 18(4). 394–402. 98 indexed citations
16.
Xiong, Nian, Jinsha Huang, Zhentao Zhang, et al.. (2009). Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease. PLoS ONE. 4(11). e7878–e7878. 95 indexed citations
17.
Liang, Zhihou, Fei Liu, Inge Grundke‐Iqbal, Khalid Iqbal, & Cheng‐Xin Gong. (2007). Down‐regulation of cAMP‐dependent protein kinase by over‐activated calpain in Alzheimer disease brain. Journal of Neurochemistry. 103(6). 2462–2470. 113 indexed citations
18.
Liu, Fei, Zhihou Liang, Jianhua Shi, et al.. (2006). PKA modulates GSK‐3β‐ and cdk5‐catalyzed phosphorylation of tau in site‐ and kinase‐specific manners. FEBS Letters. 580(26). 6269–6274. 116 indexed citations
19.
Wang, Tao, et al.. (2004). Systematic examination of DNA variants in the parkin gene in patients with Parkinson's disease.. PubMed. 117(10). 1567–9. 2 indexed citations
20.
Wang, Tao, Zhihou Liang, Shenggang Sun, et al.. (2003). [A novel point mutation in parkin gene was identified in an early-onset case of Parkinson's disease].. PubMed. 20(2). 111–3. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keun‐A Chang Breakdown of academic impact, for papers by Othman Ghribi Breakdown of academic impact, for papers by Ester Verdaguer Breakdown of academic impact, for papers by Anna M. Canudas Breakdown of academic impact, for papers by Virve Cavallucci Breakdown of academic impact, for papers by Waldo Cerpa Breakdown of academic impact, for papers by Guylène Page Breakdown of academic impact, for papers by Sandra Moreno Breakdown of academic impact, for papers by Panchanan Maiti Breakdown of academic impact, for papers by Giuseppina Amadoro
Rankless by CCL
2026